| Primary |
| Back Pain |
20.0% |
| Confusional State |
20.0% |
| Gastrointestinal Angiodysplasia |
20.0% |
| Hypertension |
20.0% |
| Product Used For Unknown Indication |
20.0% |
|
|
| Secondary |
| Product Used For Unknown Indication |
44.0% |
| Drug Abuse |
34.6% |
| Pain |
3.9% |
| Drug Use For Unknown Indication |
2.4% |
| Analgesic Therapy |
1.7% |
| Laparoscopy |
1.5% |
| Hypertension |
1.4% |
| Phantom Pain |
1.2% |
| Rheumatoid Arthritis |
1.2% |
| Infection Prophylaxis |
1.1% |
| Inflammation |
0.9% |
| Postoperative Analgesia |
0.9% |
| Thrombosis Prophylaxis |
0.9% |
| Antiinflammatory Therapy |
0.8% |
| Sinusitis |
0.8% |
| Allergy Test |
0.6% |
| Hyperparathyroidism Secondary |
0.6% |
| Prophylaxis |
0.6% |
| Asthma |
0.5% |
| Drug Therapy |
0.5% |
|
| Stevens-johnson Syndrome |
11.4% |
| Agranulocytosis |
9.1% |
| Vomiting |
9.1% |
| Leukopenia |
6.8% |
| Suicide Attempt |
6.8% |
| Myocardial Infarction |
4.5% |
| Ocular Discomfort |
4.5% |
| Pain |
4.5% |
| Pancytopenia |
4.5% |
| Rash |
4.5% |
| Rash Erythematous |
4.5% |
| Rhinitis |
4.5% |
| Surgery |
4.5% |
| Thrombocytopenia |
4.5% |
| Toxic Epidermal Necrolysis |
4.5% |
| Anaesthetic Complication Neurological |
2.3% |
| Anencephaly |
2.3% |
| Chills |
2.3% |
| Foot Deformity |
2.3% |
| Hypotension |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.9% |
| Drug Use For Unknown Indication |
12.5% |
| Pain |
12.3% |
| Rheumatoid Arthritis |
9.0% |
| Hypertension |
7.6% |
| Prophylaxis |
5.5% |
| Non-small Cell Lung Cancer |
3.4% |
| Osteoporosis |
2.8% |
| Thrombosis Prophylaxis |
2.3% |
| Multiple Myeloma |
2.2% |
| Depression |
1.6% |
| Breast Cancer |
1.5% |
| Crohn's Disease |
1.4% |
| Hiv Infection |
1.3% |
| Diabetes Mellitus |
1.2% |
| Multiple Sclerosis |
1.2% |
| Analgesic Therapy |
1.2% |
| Infection Prophylaxis |
1.2% |
| Colorectal Cancer Metastatic |
1.0% |
| Nausea |
1.0% |
|
| Vomiting |
12.2% |
| General Physical Health Deterioration |
8.3% |
| Sepsis |
7.2% |
| Thrombocytopenia |
6.6% |
| Progressive Multifocal Leukoencephalopathy |
5.5% |
| Pneumonia |
5.0% |
| Septic Shock |
5.0% |
| Acute Respiratory Distress Syndrome |
4.4% |
| Death |
4.4% |
| Mucosal Inflammation |
4.4% |
| Nausea |
4.4% |
| Shock |
4.4% |
| Pyrexia |
3.9% |
| Rectal Haemorrhage |
3.9% |
| Urinary Tract Infection |
3.9% |
| Hydrocephalus |
3.3% |
| Renal Failure |
3.3% |
| Sudden Death |
3.3% |
| Vertigo |
3.3% |
| White Blood Cell Count Decreased |
3.3% |
|
| Interacting |
| Product Used For Unknown Indication |
26.7% |
| Angina Pectoris |
8.9% |
| Type 2 Diabetes Mellitus |
8.9% |
| Delirium |
6.7% |
| Pain |
6.7% |
| Post Herpetic Neuralgia |
6.7% |
| Blood Pressure Increased |
4.4% |
| Bone Pain |
4.4% |
| Cholelithiasis |
4.4% |
| Hormone Therapy |
4.4% |
| Neoplasm Malignant |
4.4% |
| Arthralgia |
2.2% |
| Cardiovascular Event Prophylaxis |
2.2% |
| Depression |
2.2% |
| Diabetes Mellitus |
2.2% |
| Pain In Extremity |
2.2% |
| Sedation |
2.2% |
|
| Thrombocytopenia |
40.0% |
| Drug Interaction |
20.0% |
| Gastrointestinal Haemorrhage |
20.0% |
| Upper Gastrointestinal Haemorrhage |
20.0% |
|
